Adapter molecule for TNFRSF1A/TNFR1 that specifically associates with the cytoplasmic domain of activated TNFRSF1A/TNFR1 mediating its interaction with FADD. Overexpression of TRADD leads to two major TNF-induced responses, apoptosis and activation of NF-kappa-B. Heterodimer with TNFRSF1A/TNFR1. Interacts with DAB2IP, FADD, HIPK2, KRT14, KRT16, KRT17, KRT18, RIPK1, SQSTM1, TRAF1, TRAF2 and TRPC4AP. Found in all examined tissues. Note: This description may include information from UniProtKB.
Molecular Function: identical protein binding; kinase binding; molecular adaptor activity; protein binding; protein complex binding; signal transducer activity; tumor necrosis factor receptor binding
Biological Process: activation of NF-kappaB transcription factor; apoptosis; caspase activation; I-kappaB kinase/NF-kappaB cascade; induction of apoptosis via death domain receptors; positive regulation of apoptosis; positive regulation of hair follicle development; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein heterooligomerization; signal transduction; tumor necrosis factor-mediated signaling pathway
Alt. Names/Synonyms: Hs.89862; MGC11078; TNFR1-associated DEATH domain protein; TNFRSF1A-associated via death domain; TRADD; tumor necrosis factor receptor type 1 associated death domain protein; Tumor necrosis factor receptor type 1-associated DEATH domain protein; tumor necrosis factor receptor-1-associated protein
LTP: The number of records in which this modification site was determined using site-specific methods. SS methods include amino acid sequencing, site-directed mutagenesis, modification site-specific antibodies, specific MS strategies, etc.